Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could simple leg exercises restore balance and blood flow after chemotherapy?

NCT ID NCT07756073

Symptom relief Sponsor: South Valley University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether combining Buerger's exercises—leg movements that stimulate blood flow—with proprioceptive drills that train balance and coordination can help elderly patients who have nerve damage from chemotherapy. The study includes 70 people aged 65 and older with chemotherapy-induced peripheral neuropathy, who will do the exercises three times a week for eight weeks. Researchers will measure changes in postural stability, foot perfusion, pain, and quality of life to see if this drug-free approach can reduce fall risk and improve daily functioning.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A combination of Buerger's exercises (leg positioning to boost blood flow) and proprioceptive drills (balance and coordination training), performed 3 times weekly for 8 weeks under physiotherapist supervision.
What this could lead to
If effective, this exercise combo could offer a drug-free way to improve balance, reduce fall risk, and enhance foot circulation in older cancer survivors with nerve damage from chemotherapy.
What could go wrong
This is a small, early-stage trial, and results may not apply to all patients. The exercises require physical effort and could be challenging for frail elderly individuals, though they are supervised.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 70 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 65 years or older * Diagnosed with CIPN for at least 3 months * Demonstrating impaired postural stability (BBS ≤ 48 or ≥2 falls in the past year) * Medically cleared for exercise * Cognitively intact (MMSE ≥ 24) * Willing and able to give consent Exclusion Criteria: * Severe peripheral arterial disease (ABI \< 0.5) * Severe postural hypotension or positional syncope * Recent orthopedic procedures or fractures (past 6 months) * Vestibular or cerebellar disorders * Uncontrolled systemic diseases * Cognitive impairment (MMSE \< 24) * Concurrent participation in another structured balance or vascular program * Lower limb ulcers or active infection * Severe visual impairment * Intolerance to positional exercises

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Buerger's exercises and proprioceptive drills on postural stability and foot perfusion in elderly patients with chemotherapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chemotherapy-induced neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Buerger's exercises and proprioceptive drills on postural stability and foot perfusion in elderly patients with chemotherapy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.